Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Rachel Miller   and   Joel Block.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.025
         
        
        
     
 
    
        
        - 
            Current status of nerve growth factor antibodies for the treatment of osteoarthritis pain. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 107(5):85-87.
            
            
                Score: 0.571
             
- 
            Targeting neurotrophic factors: Novel approaches to musculoskeletal pain. Pharmacol Ther. 2020 07; 211:107553.
            
            
                Score: 0.170
             
- 
            What is new in pain modification in osteoarthritis? Rheumatology (Oxford). 2018 05 01; 57(suppl_4):iv99-iv107.
            
            
                Score: 0.149
             
- 
            Nerve growth factor blockade for the management of osteoarthritis pain: what can we learn from clinical trials and preclinical models? Curr Opin Rheumatol. 2017 01; 29(1):110-118.
            
            
                Score: 0.136